Trastuzumab duocarmazine
Based on 1 Customer Validation
Trastuzumab duocarmazine ((vic)-Trastuzumab duocarmazine) is a HER2-targeting ADC that is recognized and cleaved by histone B in tumor cells and selectively targets tumor cells. Trastuzumab duocarmazine has anti-tumor activity and can be used in cancer research related to uterine and ovarian sarcomas.
For research use only. We do not sell to patients.
- Purity : 99.87%
- CAS No.: 1642152-40-6
- Molecular Weight:149000 (average)
-
Storage:
-80°C, protect from light
Biological Activity
Description
In Vitro
Trastuzumab duocarmazine (SYD985) (0.0001-100 μg/mL, 24 h) is lethal to both HER2- and HER2+ cells, and is 7-fold more lethal to HER2/NEU3+ cell lines with the IC50 value of 0.013 μg/mL compared to T-DM1 with the IC50 value of 0.096 μg/mL. More importantly, in HER2/NEU1+ cells, it is 54 times more potent in killing cells compared to T-DM1[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1642152-40-6
-
Appearance Liquid
-
Molecular Weight 149000 (average)
-
Color Colorless to light yellow
-
SMILES
[Trastuzumab duocarmazine]
-
Synonyms
(vic)-Trastuzumab duocarmazine
-
Shipping
Shipping with dry ice.
-
Storage
-80°C, protect from light
Purity & Documentation
-
Data Sheet (257 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)